Q1 Loss Wider than Expected at Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 10:20AM CDT
Amedisys Inc. (AMED) recorded an adjusted loss from continuing operations of 7 cents per share in the first quarter of 2014.
Thoratec Beats on Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 8:43AM CDT
Since the earnings announcement, shares of Thoratec Corporation (THOR) dipped 3.7%.
Loss Wider than Ests, Poor Margins at BioScrip; Shares Sink - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri May 09, 11:50AM CDT
BioScrip, Inc. (BIOS) recently declared its first-quarter 2014 results.
Abiomed Sees Flat Q4 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 9:00AM CDT
For fiscal 2015, Abiomed (ABMD) forecasted revenues between $205 and $212 million for the year.
Natus to Present at Bank of America Merrill Lynch 2014 Health Care Conference
GlobeNewswire - Thu May 08, 6:31AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas, NV. Mr. Hawkins is scheduled to present at 10:00 a.m. Pacific Time on Tuesday, May 13, 2014.
DexCom Misses, Sees Broader Q1 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 06, 8:32AM CDT
DexCom's (DXCM) total revenues surged 59.1% to $47.1 million, topping the Zacks Consensus Estimate of $44.0 million.
Natus to Present at UBS Global Healthcare Conference
Business Wire - Mon May 05, 6:30AM CDT
Natus Medical Incorporated (NASDAQ: BABY) today announced that Jonathan Kennedy, Sr. Vice President and Chief Financial Officer, will present at the UBS Global Healthcare Conference in New York City. Mr. Kennedy is scheduled to present at 11:30 a.m. Eastern Time (8:30 a.m. PT) on Monday, May 19, 2014.
Teleflex 1Q Earnings Rise, Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 2:03PM CDT
For 2014, Teleflex continues to expect revenue growth between 6.0 and 8.0% versus 2013.
Haemonetics Slips on Q4 Earnings and Revs Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 1:50PM CDT
Haemonetics Corporation (HAE) reports disappointing fourth-quarter and fiscal 2014 financial results.
Luminex 1Q Earnings Rise 50%, Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 1:13PM CDT
For 2014, Luminex reiterated its revenue guidance in the range of $225 to $240 million, reflecting an increase of 5 to 12% over 2013.
Abaxis' Fiscal Q4 Earnings, Revs Disappoint Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 10:50AM CDT
Abaxis, Inc. (ABAX) delivers disappointing fourth-quarter and fiscal 2014 financial results
RadNet (RDNT) Catches Eye: Stock Rises 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 8:46AM CDT
RadNet (RDNT) was a big mover last session, with shares rising over 6% on the day.
AmSurg Lags Q1 Earnings & Revs, Trims 2014 EPS View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 8:40AM CDT
AmSurg Corp. (AMSG) delivers disappointing first-quarter 2014 financial results.
Align Technology Beats on Top & Bottom, Guides High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 8:11AM CDT
Align Technology Inc. (ALGN) delivers better-than-expected first-quarter 2014 results.
3 Stocks Rising on Big Volume
at The Street - Thu Apr 24, 8:18AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Natus Medical posts higher net income of USD6.3m for Q1 2014
M2 - Thu Apr 24, 5:55AM CDT
Healthcare company Natus Medical (NasdaqGS:BABY) disclosed on Wednesday its net income of USD6.3m (USD0.19 per diluted share) for the three months ended 31 March 2014.
Why Natus Medical (BABY) Stock Is Soaring Today
at The Street - Wed Apr 23, 12:44PM CDT
Shares of Natus Medical (BABY) are surging, up 6.60% to $26.00, after the healthcare products company reported financial results for the 2014 first quarter.
Natus, Skechers Rally, But Techs Drag Indexes Lower
at Investor's Business Daily - Wed Apr 23, 11:07AM CDT
The major averages were trading near their intraday lows in midday trade as tech stocks sold off hard. Software-makers and biotechs weighed on the Nasdaq, which was down 0.5%. The Dow and S&P 500 were each off 0.1%. Volume was tracking lower across...
Natus Medical Announces First Quarter 2014 Financial Results
Business Wire - Wed Apr 23, 6:31AM CDT
--Reports non-GAAP gross profit margin of 59.5%
Uptrend Call Working As Natus Medical Stock Rises 60.6% (BABY)
Comtex SmarTrend(R) - Fri Apr 11, 4:48PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on October 2nd, 2013 at $14.42. In approximately 6 months, Natus Medical has returned 60.61% as of today's recent price of $23.16.